Trial Profile
Drug-drug interactions study of tildrakizumab in patients with moderate to severe psoriasis.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2018
Price :
$35
*
At a glance
- Drugs Tildrakizumab (Primary) ; Caffeine; Dextromethorphan; Midazolam; Omeprazole; Warfarin
- Indications Psoriasis
- Focus Pharmacokinetics
- 12 Jun 2018 Results published in the British Journal of Clinical Pharmacology
- 08 Jun 2017 New trial record